Articles Tagged With:
-
Conflict of interest issues raised by subject's suicide
When is the dual role of physician/investigator a conflict of interest? This is the question IRBs might consider in the aftermath of clinical trial participant Dan Markingson's suicide. -
Full August 2008 Issue in PDF
-
Elements of an incidental findings management plan
When the answer to the question of "Could there be incidental findings from this study?" is "Yes," experts agree that the protocol should include an incidental findings management plan. -
When clinical research turns up the unexpected
Researchers using magnetic resonance imaging (MRI) in a cognitive psychology study note a suspicious mass in the brain of a supposedly healthy volunteer. -
In rare instances, IRBs may need to go beyond regulatory framework
Sometimes IRB members will need to view a particular human subject research issue with more of an eye on what is the most ethical decision to make, as opposed to what is the best way to comply with rules and regulations. -
Clinical trial participant's suicide raises ethical questions for IRBs
A recent legal case involving a clinical trial participant who committed suicide raises a variety of questions for IRBs. -
Pharmacology Watch
Baxter Bioscience has developed a whole-virus, two dose vaccine against avian flu; warning label now on antipsychotics regarding an increased risk of mortality in elderly patients treated for dementia-related psychosis; vitamin D for men with heart disease on horizon? A new oral anticoagulant may soon be available for prevention of thrombotic complications of hip or knee surgery; FDA Actions -
Full August 1, 2008 Issue in PDF
-
Clinical Briefs in Primary Care Supplement
-
Full August 2008 Issue in PDF